wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q35918752-28A0460E-548E-49D2-8CAB-BAFB2A3A650F
Q35918752-28A0460E-548E-49D2-8CAB-BAFB2A3A650F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35918752-28A0460E-548E-49D2-8CAB-BAFB2A3A650F
Clinical, pharmacokinetic and pharmacodynamic evaluations of metronomic UFT and cyclophosphamide plus celecoxib in patients with advanced refractory gastrointestinal cancers
P2860
Q35918752-28A0460E-548E-49D2-8CAB-BAFB2A3A650F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35918752-28A0460E-548E-49D2-8CAB-BAFB2A3A650F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
1ba6d80bceed9831521a8c21ff98706355b701b1
P2860
Phase II clinical trial results involving treatment with low-dose daily oral cyclophosphamide, weekly vinblastine, and rofecoxib in patients with advanced solid tumors.